Pfizer to Acquire Metsera in $7.3 Billion Obesity Drug Deal

The acquisition aims to expand Pfizer’s pipeline of obesity treatments, marking a major push into the fast-growing weight-loss drug market.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Acquisition: A corporate transaction in which one company purchases most or all of another company's shares or assets to gain control.
  • Pipeline: A term used in the pharmaceutical industry to describe a company's portfolio of drug candidates under development.
  • Obesity Treatments: Medical or pharmaceutical interventions designed to help individuals reduce or manage excess body weight.